slides · global inventory
All filtered slides
Global slide inventory for the active corpus filters, with each row opening the slide detail view.
Corpus coverage
319,975 slides
319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.
- Total slides
- 319,975
- Described
- 319,974
- Pending
- 1
100%ready for canon
Slide type composition
dynamicclickable
Slide type
Showing 319,974 described slides — 100.0% of 319,975 rendered pages
+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs
Tile area is proportional to slide count. Click a category to open its subtype map.
all document kinds · all orientations
Slide collection
197,461-197,520 of 319,975
06
The diagram uses a hub-and-spoke style layout to show equity stakes and management agreements.Citi | Investment Banking Pitch Book | 20 slides · Citi
Consulting deck Investment bank Beat · Situation & Context1 hit
07
The slide uses a standard table format to present deal terms, including acquirer, scope, consideration, and financing status.Citi | Investment Banking Pitch Book | 20 slides · Citi
Consulting deck Investment bank 1 hit
08
Citi | Investment Banking Pitch Book | 20 slidesCiti | Investment Banking Pitch Book | 20 slides · Citi
Consulting deck Investment bank 1 hit
09
The table includes a mix of public companies and private equity-backed operators, with specific investment dates noted for the latter.Citi | Investment Banking Pitch Book | 20 slides · Citi
Consulting deck Investment bank Beat · Problem & Complication1 hit
10
The slide uses a list-based comparison format to illustrate financial distress and restructuring outcomes for specific companies.Citi | Investment Banking Pitch Book | 20 slides · Citi
Consulting deck Investment bank Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
11
The slide combines a timeline, a line chart for stock performance, and a summary financial table.Citi | Investment Banking Pitch Book | 20 slides · Citi
Consulting deck Investment bank Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
12
The slide uses a structured table format to compare key operational and financial KPIs for five companies: Alerislife, Brookdale, Sonida, Ensign Group, and Pennant Group.Citi | Investment Banking Pitch Book | 20 slides · Citi
Consulting deck Investment bank 1 hit
13
Includes a COVID-19 shaded region for context. Data sourced from FactSet.Citi | Investment Banking Pitch Book | 20 slides · Citi
Consulting deck Investment bank 1 hit
14
Citi | Investment Banking Pitch Book | 20 slidesCiti | Investment Banking Pitch Book | 20 slides · Citi
Consulting deck Investment bank Beat · Solution & ApproachLoop · Mece Breakdown1 hit
15
The slide uses a table-like structure with categories on the left and bulleted assumptions on the right.Citi | Investment Banking Pitch Book | 20 slides · Citi
Consulting deck Investment bank Beat · Solution & ApproachLoop · Mece Breakdown1 hit
16
Includes detailed footnotes regarding adjustments, tax rates, and source data.Citi | Investment Banking Pitch Book | 20 slides · Citi
Consulting deck Investment bank Beat · Solution & ApproachLoop · Mece Breakdown1 hit
17
Includes a disclaimer about the preliminary nature of the data and specific assumptions regarding tax rates and debt.Citi | Investment Banking Pitch Book | 20 slides · Citi
Consulting deck Investment bank Beat · Solution & Approach1 hit
18
Citi | Investment Banking Pitch Book | 20 slidesCiti | Investment Banking Pitch Book | 20 slides · Citi
Consulting deck Investment bank Beat · Evidence & Proof1 hit
19
Includes disclaimer about preliminary nature and data sources.Citi | Investment Banking Pitch Book | 20 slides · Citi
Consulting deck Investment bank Beat · Evidence & Proof1 hit
20
Includes a pie chart showing ownership distribution and a table detailing the top 25 investors by name, type, and percentage.Citi | Investment Banking Pitch Book | 20 slides · Citi
Consulting deck Investment bank 1 hit
01
Comera | Investor Presentation Deck | 22 slidesComera | Investor Presentation Deck | 22 slides · Comera Life Sciences
Pitch deck Investor relations Beat · Attention1 hit
02
Comera | Investor Presentation Deck | 22 slidesComera | Investor Presentation Deck | 22 slides · Comera Life Sciences
Pitch deck Investor relations 1 hit
03
Comera | Investor Presentation Deck | 22 slidesComera | Investor Presentation Deck | 22 slides · Comera Life Sciences
Pitch deck Investor relations Beat · Interest1 hit
01
Includes a molecular visualization graphic.Compass Therapeutics | Investor Presentation Deck | 20 slides · Compass Therapeutics
Pitch deck Investor relations 1 hit
02
Compass Therapeutics | Investor Presentation Deck | 20 slidesCompass Therapeutics | Investor Presentation Deck | 20 slides · Compass Therapeutics
Pitch deck Investor relations 1 hit
03
The slide explains the mechanism of action for a bispecific antibody, contrasting single-target blockade with dual-target blockade.Compass Therapeutics | Investor Presentation Deck | 20 slides · Compass Therapeutics
Pitch deck Investor relations Beat · Solution1 hit
04
The slide outlines a standard Simon 2-stage design, a common statistical framework in oncology trials to allow for early stopping for futility.Compass Therapeutics | Investor Presentation Deck | 20 slides · Compass Therapeutics
Pitch deck Investor relations Beat · Product1 hit
05
The table is split into two columns, both representing the same cohort of 24 patients.Compass Therapeutics | Investor Presentation Deck | 20 slides · Compass Therapeutics
Pitch deck Investor relations Beat · Product1 hit
06
The chart is a classic waterfall plot used in oncology clinical trials to demonstrate efficacy.Compass Therapeutics | Investor Presentation Deck | 20 slides · Compass Therapeutics
Pitch deck Investor relations Beat · ProductLoop · Cost Of Inaction1 hit
07
Clinical trial data visualization showing patient-level progression, response (PR, SD, PD), and status (death, ongoing).Compass Therapeutics | Investor Presentation Deck | 20 slides · Compass Therapeutics
Pitch deck Investor relations Beat · ProductLoop · Cost Of Inaction1 hit
08
Clinical trial data presentation.Compass Therapeutics | Investor Presentation Deck | 20 slides · Compass Therapeutics
Pitch deck Investor relations Beat · ProductLoop · Cost Of Inaction1 hit
09
Standard clinical trial survival analysis plots.Compass Therapeutics | Investor Presentation Deck | 20 slides · Compass Therapeutics
Pitch deck Investor relations 1 hit
10
The slide compares clinical trial data for a specific combination therapy against known label safety profiles of individual components.Compass Therapeutics | Investor Presentation Deck | 20 slides · Compass Therapeutics
Pitch deck Investor relations 1 hit
11
Comparison of CTX-009 efficacy metrics (ORR, PFS, OS) against FOLFOX and TOPAZ-1 benchmarks.Compass Therapeutics | Investor Presentation Deck | 20 slides · Compass Therapeutics
Pitch deck Investor relations 1 hit
12
The diagram outlines the randomization, treatment regimen, disease progression assessment, and study endpoints.Compass Therapeutics | Investor Presentation Deck | 20 slides · Compass Therapeutics
Pitch deck Investor relations 1 hit
13
The slide uses a table for market sizing and a structured layout to contrast 1L and 2L treatment pathways.Compass Therapeutics | Investor Presentation Deck | 20 slides · Compass Therapeutics
Pitch deck Investor relations Beat · Problem1 hit
14
The table highlights Partial Response (PR) rates with a red border, emphasizing clinical activity.Compass Therapeutics | Investor Presentation Deck | 20 slides · Compass Therapeutics
Pitch deck Investor relations Beat · Market Size1 hit
15
The slide depicts a standard Simon 2-stage design, a common statistical framework for phase II oncology trials.Compass Therapeutics | Investor Presentation Deck | 20 slides · Compass Therapeutics
Pitch deck Investor relations Beat · Market Size1 hit
16
The slide provides epidemiological data and clinical treatment pathways for CRC, highlighting the limited efficacy of current 3L treatments.Compass Therapeutics | Investor Presentation Deck | 20 slides · Compass Therapeutics
Pitch deck Investor relations Beat · Market Size1 hit
17
The slide uses a three-column layout to represent distinct clinical study tracks with initiation dates.Compass Therapeutics | Investor Presentation Deck | 20 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
18
This appears to be a slide introducing an advisor or team member.Compass Therapeutics | Investor Presentation Deck | 20 slides · Compass Therapeutics
Pitch deck Investor relations Beat · Team1 hit
19
The table compares a small N=24 study (CTX-009) against larger historical studies (N=81 to N=341).Compass Therapeutics | Investor Presentation Deck | 20 slides · Compass Therapeutics
Pitch deck Investor relations Beat · Competition1 hit
20
Compass Therapeutics | Investor Presentation Deck | 20 slidesCompass Therapeutics | Investor Presentation Deck | 20 slides · Compass Therapeutics
Pitch deck Investor relations 1 hit
01
Crocs | Investor Presentation Deck | 29 slidesCrocs | Investor Presentation Deck | 29 slides · Crocs
Conference presentation Investor relations 1 hit
02
Crocs | Investor Presentation Deck | 29 slidesCrocs | Investor Presentation Deck | 29 slides · Crocs
Conference presentation Investor relations 1 hit
03
The background features a repeating pattern of Crocs shoe outlines.Crocs | Investor Presentation Deck | 29 slides · Crocs
Conference presentation Investor relations 1 hit
04
Slide highlights strong financial health and successful integration of the HEYDUDE brand.Crocs | Investor Presentation Deck | 29 slides · Crocs
Conference presentation Investor relations 1 hit
05
Crocs | Investor Presentation Deck | 29 slidesCrocs | Investor Presentation Deck | 29 slides · Crocs
Conference presentation Investor relations 1 hit
06
The chart highlights Crocs Inc. in green to distinguish it from the grey bars of competitors.Crocs | Investor Presentation Deck | 29 slides · Crocs
Conference presentation Investor relations Beat · Business Model1 hit
07
The pie chart segments the market into Casual ($125B), Sandals ($30B), Clogs ($8B), and Other ($142B).Crocs | Investor Presentation Deck | 29 slides · Crocs
Conference presentation Investor relations Beat · Market Size1 hit
08
The slide highlights the scale and growth profile of the two brands under the Crocs, Inc. umbrella.Crocs | Investor Presentation Deck | 29 slides · Crocs
Conference presentation Investor relations 1 hit
09
Crocs | Investor Presentation Deck | 29 slidesCrocs | Investor Presentation Deck | 29 slides · Crocs
Conference presentation Investor relations 1 hit
10
The slide uses donut charts to visualize the percentage split for each category.Crocs | Investor Presentation Deck | 29 slides · Crocs
Conference presentation Investor relations 1 hit
11
The slide uses a comparison frame to show that HEYDUDE has significant international growth potential compared to the established Crocs brand.Crocs | Investor Presentation Deck | 29 slides · Crocs
Conference presentation Investor relations 1 hit
12
The slide uses house-shaped icons to emphasize growth metrics.Crocs | Investor Presentation Deck | 29 slides · Crocs
Conference presentation Investor relations 1 hit
13
Crocs | Investor Presentation Deck | 29 slidesCrocs | Investor Presentation Deck | 29 slides · Crocs
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
14
The slide features a portrait of the speaker and the title of the presentation section.Crocs | Investor Presentation Deck | 29 slides · Crocs
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
15
Crocs | Investor Presentation Deck | 29 slidesCrocs | Investor Presentation Deck | 29 slides · Crocs
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
16
The slide uses a four-column layout to highlight key financial KPIs.Crocs | Investor Presentation Deck | 29 slides · Crocs
Conference presentation Investor relations Beat · Financials1 hit
17
Includes a timeline-style annotation at the bottom indicating 'Transformation & Brand Re-ignition' followed by 'Profitable Growth'.Crocs | Investor Presentation Deck | 29 slides · Crocs
Conference presentation Investor relations Beat · Financials1 hit
18
The slide uses a bar chart for regional growth and a callout box for digital/DTC metrics.Crocs | Investor Presentation Deck | 29 slides · Crocs
Conference presentation Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
19
The slide highlights rapid revenue growth and includes a specific callout for digital penetration.Crocs | Investor Presentation Deck | 29 slides · Crocs
Conference presentation Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
20
Crocs | Investor Presentation Deck | 29 slidesCrocs | Investor Presentation Deck | 29 slides · Crocs
Conference presentation Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
21
Uses large numbered outlines as a visual hierarchy for priorities.Crocs | Investor Presentation Deck | 29 slides · Crocs
Conference presentation Investor relations Beat · Financials1 hit
22
Includes a callout regarding a $300M debt repayment in Q4.Crocs | Investor Presentation Deck | 29 slides · Crocs
Conference presentation Investor relations Beat · Financials1 hit